Patents by Inventor Guenther Grabner
Guenther Grabner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10842671Abstract: Glaucoma can be treated by implanting an intraocular shunt into the eye. Such procedures can employ various deployment devices, shunts, and implantation techniques. A method for treating glaucoma can include positioning an intraocular shunt in eye tissue such that the shunt conducts fluid from the anterior chamber to the suprachoroidal space and delivers a pharmaceutical or biological agent to the eye.Type: GrantFiled: May 12, 2016Date of Patent: November 24, 2020Assignee: AqueSys, Inc.Inventors: Christopher Horvath, Ronald D. Bache, Laszlo O. Romoda, Guenther Grabner, Herbert A. Reitsamer, John R. Samples
-
Publication number: 20190240069Abstract: Glaucoma can be treated by implanting an intraocular shunt into the eye. Such procedures can employ various deployment devices, shunts, and implantation techniques. A method of treating glaucoma can be performed by a clinician, in which a hollow needle is inserted into an eye through the sclera. The hollow needle can carry an intraocular shunt. Once inserted and properly positioned, the clinician can release the shunt from the needle such that the shunt conducts fluid away from the anterior chamber of the eye.Type: ApplicationFiled: April 17, 2019Publication date: August 8, 2019Inventors: Christopher HORVATH, Laszlo O. ROMODA, Guenther GRABNER, Herbert A. REITSAMER
-
Publication number: 20190167475Abstract: Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be present to provide an initial flow restriction and subsequent increase in flow over time.Type: ApplicationFiled: February 4, 2019Publication date: June 6, 2019Inventors: Christopher HORVATH, Laszlo O. ROMODA, Brian HAMSTROM, Ronald D. BACHE, Guenther GRABNER, Herbert A. REITSAMER
-
Patent number: 10195079Abstract: Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be present to provide an initial flow restriction and subsequent increase in flow over time.Type: GrantFiled: May 17, 2016Date of Patent: February 5, 2019Assignee: AqueSys, Inc.Inventors: Christopher Horvath, Laszlo O. Romoda, Brian Hamstrom, Ronald D. Bache, Guenther Grabner, Herbert A. Reitsamer
-
Patent number: 10195078Abstract: Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be present to provide an initial flow restriction and subsequent increase in flow over time.Type: GrantFiled: May 16, 2016Date of Patent: February 5, 2019Assignee: AqueSys, Inc.Inventors: Christopher Horvath, Laszlo O. Romoda, Brian Hamstrom, Ronald D. Bache, Guenther Grabner, Herbert A. Reitsamer
-
Patent number: 10159600Abstract: Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be present to provide an initial flow restriction and subsequent increase in flow over time.Type: GrantFiled: February 19, 2013Date of Patent: December 25, 2018Assignee: AqueSys, Inc.Inventors: Christopher Horvath, Laszlo O. Romoda, Brian Hamstrom, Ronald D. Bache, Guenther Grabner, Herbert A. Reitsamer
-
Patent number: 10085884Abstract: Glaucoma can be treated by implanting an intraocular shunt into the eye. Such procedures can employ various deployment devices, shunts, and implantation techniques.Type: GrantFiled: June 24, 2014Date of Patent: October 2, 2018Assignee: AQUESYS, INC.Inventors: Herbert A. Reitsamer, Guenther Grabner, Christopher Horvath, Laszlo O. Romoda
-
Publication number: 20160256322Abstract: Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be present to provide an initial flow restriction and subsequent increase in flow over time.Type: ApplicationFiled: May 17, 2016Publication date: September 8, 2016Inventors: Christopher HORVATH, Laszlo O. ROMODA, Brian HAMSTROM, Ronald D. BACHE, Guenther GRABNER, Herbert A. REITSAMER
-
Publication number: 20160256317Abstract: Glaucoma can be treated by implanting an intraocular shunt into the eye. Such procedures can employ various deployment devices, shunts, and implantation techniques. A method for treating glaucoma can include positioning an intraocular shunt in eye tissue, without use of an optical apparatus that contacts the eye, such that the shunt conducts fluid from the anterior chamber of the eye and delivers a pharmaceutical or biological agent to the eye.Type: ApplicationFiled: May 12, 2016Publication date: September 8, 2016Inventors: Christopher HORVATH, Laszlo O. ROMODA, Guenther GRABNER, Herbert A. REITSAMER
-
Publication number: 20160256319Abstract: Glaucoma can be treated by implanting an intraocular shunt into the eye. Such procedures can employ various deployment devices, shunts, and implantation techniques. A method for treating glaucoma can include positioning an intraocular shunt in eye tissue such that the shunt conducts fluid from the anterior chamber to the suprachoroidal space and delivers a pharmaceutical or biological agent to the eye.Type: ApplicationFiled: May 12, 2016Publication date: September 8, 2016Inventors: Christopher HORVATH, Ronald D. BACHE, Laszlo O. ROMODA, Guenther GRABNER, Herbert A. REITSAMER, John R. SAMPLES
-
Publication number: 20160256318Abstract: Glaucoma can be treated by implanting an intraocular shunt into the eye. Such procedures can employ various deployment devices, shunts, and implantation techniques. A method for treating glaucoma can include positioning an intraocular shunt in eye tissue such that the shunt conducts fluid from the anterior chamber to the suprachoroidal space and delivers a pharmaceutical or biological agent to the eye.Type: ApplicationFiled: May 12, 2016Publication date: September 8, 2016Inventors: Christopher HORVATH, Ronald D. BACHE, Laszlo O. ROMODA, Guenther GRABNER, Herbert A. REITSAMER, John R. SAMPLES
-
Publication number: 20160256321Abstract: Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be present to provide an initial flow restriction and subsequent increase in flow over time.Type: ApplicationFiled: May 16, 2016Publication date: September 8, 2016Inventors: Christopher HORVATH, Laszlo O. ROMODA, Brian HAMSTROM, Ronald D. BACHE, Guenther GRABNER, Herbert A. REITSAMER
-
Publication number: 20160256320Abstract: Glaucoma can be treated by implanting an intraocular shunt into the eye. Such procedures can employ various deployment devices, shunts, and implantation techniques. A method for treating glaucoma can include injecting a drug into the eye and positioning an intraocular shunt in eye tissue such that the shunt conducts fluid from the anterior chamber to the suprachoroidal space.Type: ApplicationFiled: May 12, 2016Publication date: September 8, 2016Inventors: Christopher HORVATH, Ronald D. BACHE, Laszlo O. ROMODA, Guenther GRABNER, Herbert A. REITSAMER, John R. SAMPLES
-
Patent number: 9326891Abstract: The present invention generally relates to methods for deploying intraocular shunts without the use of an optical apparatus that contacts an eye, such as a goniolens. In certain embodiments, methods of the invention involve inserting into an eye a deployment device configured to hold an intraocular shunt, determining that a distal portion of the device is properly positioned within the eye without use of an optical apparatus that contacts the eye, and deploying the shunt from the device.Type: GrantFiled: May 15, 2013Date of Patent: May 3, 2016Assignee: AqueSys, Inc.Inventors: Christopher Horvath, Laszlo O. Romoda, Guenther Grabner, Herbert A. Reitsamer
-
Patent number: 9125723Abstract: Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be present to provide an initial flow restriction and subsequent increase in flow over time.Type: GrantFiled: February 19, 2013Date of Patent: September 8, 2015Assignee: AqueSys, Inc.Inventors: Christopher Horvath, Laszlo O. Romoda, Brian Hamstrom, Ronald D. Bache, Guenther Grabner, Herbert A. Reitsamer
-
Patent number: 9095411Abstract: The present invention generally relates to devices for deploying intraocular shunts without the use of an optical apparatus that contacts an eye, such as a goniolens. In certain embodiments, devices of the invention include a housing including a proximal portion and a distal portion, in which the distal portion is movable within the proximal portion, a deployment mechanism at least partially disposed within the housing, and a hollow shaft coupled to the deployment mechanism, in which the shaft is configured to hold an intraocular shunt.Type: GrantFiled: November 15, 2010Date of Patent: August 4, 2015Assignee: AqueSys, Inc.Inventors: Christopher Horvath, Laszlo O. Romoda, Guenther Grabner, Herbert A. Reitsamer
-
Publication number: 20150011926Abstract: Glaucoma can be treated by implanting an intraocular shunt into the eye. Such procedures can employ various deployment devices, shunts, and implantation techniques.Type: ApplicationFiled: June 24, 2014Publication date: January 8, 2015Inventors: Herbert A. Reitsamer, Guenther Grabner, Christopher Horvath, Laszlo O. Romoda
-
Patent number: 8852137Abstract: The invention generally relates to methods for implanting a soft gel shunt in the suprachoroidal space. In certain embodiments, methods of the invention involve inserting into the eye a hollow shaft configured to hold a soft gel intraocular shunt, deploying the soft gel shunt from the hollow shaft such that the shunt forms a passage from the anterior chamber of the eye to the suprachoroidal space of the eye, and withdrawing the hollow shaft from the eye.Type: GrantFiled: December 23, 2011Date of Patent: October 7, 2014Assignee: AqueSys, Inc.Inventors: Christopher Horvath, Ronald D. Bache, Laszlo O. Romoda, Guenther Grabner, Herbert A. Reitsamer, John R. Samples
-
Patent number: 8828070Abstract: The present invention generally relates to devices for deploying intraocular shunts without the use of an optical apparatus that contacts an eye, such as a goniolens. In certain embodiments, devices of the invention include a housing, in which a distal end of the housing includes a protrusion, a deployment mechanism at least partially disposed within the housing, and a hollow shaft coupled to the deployment mechanism, in which the shaft is configured to hold an intraocular shunt.Type: GrantFiled: November 15, 2010Date of Patent: September 9, 2014Assignee: AqueSys, Inc.Inventors: Laszlo O. Romoda, Christopher Horvath, Guenther Grabner, Herbert A. Reitsamer
-
Publication number: 20140236067Abstract: Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be present to provide an initial flow restriction and subsequent increase in flow over time.Type: ApplicationFiled: February 19, 2013Publication date: August 21, 2014Applicant: AQUESYS, INC.Inventors: Christopher HORVATH, Laszlo O. ROMODA, Brian HAMSTROM, Ronald D. BACHE, Guenther GRABNER, Herbert A. REITSAMER